SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
SAN
92.06
+2.59%↑
SHL.DE
49.22
+0.94%↑
ARGX
503
+3.65%↑
FRE
42.91
+0.73%↑
ONC.US
228.61
+1.33%↑
24h
Praegune
Min
113.25
Max
117
Sissetulek | -142M 667M |
---|---|
Müük | 152M 5.4B |
P/E Sektori keskmine | 26.27 56.602 |
Aktsiakasum | 2.2 |
Dividenditootlus | 1.34 |
Kasumimarginaal | 12.311 |
EBITDA | 85M 1.6B |
Soovitused | Osta |
---|---|
12 kuu keskmine prognoos | +42.4% upside |
Dividenditootlus Sektori keskmine | 1.34% 2.45% |
---|---|
Järgmine tulemuste avaldamine | 7. aug 2025 |
Turukapital | 33B 98B |
---|---|
Eelmine avamishind | 115.66 |
Eelmine sulgemishind | 114.45 |
By Acuity
30%
70%
80 / 382 Pingereas Healthcare
By Trading Central
Kindlus
Strong Bearish Evidence
121.15 / 123.55 Toetus ja vastupanu
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
15. mai 2025, 08:36 UTC
Merck KGaA Shares Plunge After Outlook Cut on Tariff, Currency Risks
DJ
Loe
15. mai 2025, 05:25 UTC
Merck KGaA Cuts Outlook Amid Macroeconomic Challenges
DJ
Loe
28. apr 2025, 11:25 UTC
Germany's Merck to Buy SpringWorks for $3.9 Billion -- Update
DJ
Loe
28. apr 2025, 06:41 UTC
Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal
DJ
Loe
15. mai 2025, 08:21 UTC
Merck KGaA Shares Slide After Outlook Cut on Tariff, Currency Risks
DJ
Loe
15. mai 2025, 06:53 UTC
Merck KGaA's Guidance Cut Should Cause Share-Price Pressure -- Market Talk
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA: Guidance Cut Reflects Impact of Current Macro-Economic, Geopolitical Environment
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA 1Q EBITDA EUR1.48B
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA Had Seen 2025 Net Sales Between EUR21.5B and EUR22.9B
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA Now Expects 2025 Net Sales Between EUR20.9B and EUR22.4B
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA Now Sees 2025 EBITDA Before One-Time Items Between EUR5.8B and EUR6.4B
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA Had Seen 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B
DJ
Loe
15. mai 2025, 05:00 UTC
Analysts Saw Merck KGaA 1Q Adj EPS at EUR2.17
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA Cuts 2025 View
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA 1Q After-Tax Profit EUR738M
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA 1Q Adj EPS EUR2.12
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA 1Q Sales EUR5.28B
DJ
Loe
15. mai 2025, 05:00 UTC
Analysts Saw Merck KGaA 1Q Ebitda Before One-Time Items EUR1.51B
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA 1Q EBIT EUR1.01B
DJ
Loe
15. mai 2025, 05:00 UTC
Merck KGaA 1Q Ebitda Before One-Time Items EUR1.535B
DJ
Loe
15. mai 2025, 05:00 UTC
Analysts Saw Merck KGaA 1Q Net Sales at EUR5.28B
DJ
Loe
28. apr 2025, 15:20 UTC
Merck KGaA's $3.9B SpringWorks Therapeutics Buy Underwhelms -- Market Talk
DJ
Loe
28. apr 2025, 09:20 UTC
Stocks to Watch Monday: DoorDash, Merck, Spirit AeroSystems, Airbus -- WSJ
DJ
Loe
28. apr 2025, 08:36 UTC
Germany's Merck's Deal to Acquire SpringWorks Makes Strategic Sense, but Price in Focus -- Market Talk
DJ
Loe
28. apr 2025, 06:06 UTC
Germany's Merck: Acquisition Will Strengthen Merck Healthcare Presence in U.S.
DJ
Loe
28. apr 2025, 06:05 UTC
Germany's Merck: Planned Acquisition Will Immediately Add Revenue, Accelerate Growth
DJ
Loe
28. apr 2025, 06:05 UTC
Germany's Merck: Deal Is for Purchase Price of $47 a Share in Cash
DJ
Loe
28. apr 2025, 06:04 UTC
Germany's Merck to Buy SpringWorks for About $3.9B
DJ
Loe
28. apr 2025, 06:02 UTC
Germany's Merck to Buy SpringWorks Therapeutics
DJ
Loe
24. apr 2025, 22:51 UTC
Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 164.33 EUR 42.4%
Kõrge 190 EUR
Madal 107 EUR
Põhineb 10 Wall Streeti analüütiku instrumendi Merck KGaA 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Osta
10 ratings
8
Osta
1
Hoia
1
Müü
Põhineb 10 analüütiku instrumendi Merck KGaA aktsia reitingul - viimase 3 kuu andmed.
By Trading Central
Lühikene perspektiiv
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Keskpikk perspektiiv
Neutral Evidence
The bullish and bearish events are balanced.
Pikk perspektiiv
Bearish Evidence
All events are bearish.
By Acuity
Uudiste sentiment
Languse märgid
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Üle keskmise
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$